Genus plc (LON:GNS - Get Free Report)'s share price passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 2,055.90 ($27.62) and traded as high as GBX 2,655 ($35.67). Genus shares last traded at GBX 2,605 ($35.00), with a volume of 92,052 shares.
Wall Street Analysts Forecast Growth
A number of research firms have commented on GNS. Deutsche Bank Aktiengesellschaft boosted their price objective on Genus from GBX 2,250 to GBX 2,550 and gave the stock a "buy" rating in a research note on Tuesday, July 15th. Shore Capital restated a "buy" rating and set a GBX 2,900 target price on shares of Genus in a research report on Thursday. Two research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average target price of GBX 2,725.
View Our Latest Report on GNS
Genus Trading Up 10.4%
The company has a market cap of £1.81 billion, a P/E ratio of -44,516.13, a P/E/G ratio of 2.87 and a beta of 0.37. The company has a quick ratio of 1.08, a current ratio of 1.80 and a debt-to-equity ratio of 53.12. The business has a 50-day moving average price of GBX 2,438.87 and a two-hundred day moving average price of GBX 2,076.02.
Genus (LON:GNS - Get Free Report) last released its earnings results on Thursday, September 4th. The company reported GBX 81.80 earnings per share for the quarter. Genus had a return on equity of 1.41% and a net margin of 1.18%. On average, analysts predict that Genus plc will post 70.9644323 EPS for the current year.
About Genus
(
Get Free Report)
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
See Also
Before you consider Genus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.
While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.